Displaying items by tag: IP protection
With vaccines widely available in Europe, it is easy to forget, even just a year-and-a-half later, the urgency with which they were developed. Duncan Matthews, an expert on IP law at Queen Mary University of London, was a key guest at the WIPO Summer School at Charles University. One of his lectures focused on the Oxford-AstraZeneca vaccine.
